Nucleoside reverse transcriptase inhibitors (NRTIs)

66 Y Pill - white oval

Pill with imprint 66 Y is White, Oval and has been identified as Lamivudine 150 mg. It is supplied by Aurobindo Pharma USA, Inc.

Lamivudine is used in the treatment of Hepatitis B; HIV Infection; Occupational Exposure; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Lamivudine (Lamivudine [ la-miv-ue-deen ])-66 Y-150 mg-White-Oval
Lamivudine (Lamivudine [ la-miv-ue-deen ])-66 Y-150 mg-White-Oval
Lamivudine (Lamivudine [ la-miv-ue-deen ])-66 Y-150 mg-White-Oval

Lamivudine
Generic Name: lamivudine [ la-miv-ue-deen ]
Imprint: 66 Y
Strength: 150 mg
Color: White
Size: N/A
Shape: Oval
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Hypromellose 2910 (5 mPa.s), Magnesium stearate, Microcrystalline cellulose, Polyethylene glycol 400, Polysorbate 80, Sodium starch glycolate type A potato, Titanium dioxide,
Latest News
Related Drugs